• Je něco špatně v tomto záznamu ?

Receptor for advanced glycation end products (RAGE) and glyoxalase I gene polymorphisms in pathological pregnancy

A. Germanová, A. Muravská, M. Jáchymová, Z. Hájek, M. Koucký, O. Mestek, T. Zima, M. Kalousová,

. 2012 ; 45 (16-17) : 1409-14.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024390

OBJECTIVES: The aim of the study was to analyze polymorphisms of receptor for advanced glycation end products (RAGE) gene, and glyoxalase I gene and soluble RAGE, sRAGE, in physiological and pathological pregnancy. DESIGN AND METHODS: Polymorphisms of RAGE gene (-429 T/C, -374 T/A, 557 G/A, 2184 A/G) and glyoxalase I gene (A419C) and sRAGE serum levels were determined in 284 women with pathological and physiological pregnancy. RESULTS: No differences in distribution of genotype and allelic frequencies of studied polymorphisms were found. GA genotype of RAGE 557 G/A polymorphism (known as Gly82Ser) is associated with lower sRAGE serum levels in healthy pregnant women compared to GG genotype (483 ± 104 vs. 692 ± 262 pg/mL, p=0.008). sRAGE correlates negatively with ALT in patients with pregnancy intrahepatic cholestasis (r=-0.536, p=0.05). CONCLUSIONS: We did not show any association of RAGE and glyoxalase I gene polymorphisms with pathological pregnancy, however further studies are needed to confirm the results.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13024390
003      
CZ-PrNML
005      
20130708100449.0
007      
ta
008      
130703s2012 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.clinbiochem.2012.06.031 $2 doi
035    __
$a (PubMed)22771726
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Germanová, Anna $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U nemocnice 2, 128 08, Prague, Czech Republic.
245    10
$a Receptor for advanced glycation end products (RAGE) and glyoxalase I gene polymorphisms in pathological pregnancy / $c A. Germanová, A. Muravská, M. Jáchymová, Z. Hájek, M. Koucký, O. Mestek, T. Zima, M. Kalousová,
520    9_
$a OBJECTIVES: The aim of the study was to analyze polymorphisms of receptor for advanced glycation end products (RAGE) gene, and glyoxalase I gene and soluble RAGE, sRAGE, in physiological and pathological pregnancy. DESIGN AND METHODS: Polymorphisms of RAGE gene (-429 T/C, -374 T/A, 557 G/A, 2184 A/G) and glyoxalase I gene (A419C) and sRAGE serum levels were determined in 284 women with pathological and physiological pregnancy. RESULTS: No differences in distribution of genotype and allelic frequencies of studied polymorphisms were found. GA genotype of RAGE 557 G/A polymorphism (known as Gly82Ser) is associated with lower sRAGE serum levels in healthy pregnant women compared to GG genotype (483 ± 104 vs. 692 ± 262 pg/mL, p=0.008). sRAGE correlates negatively with ALT in patients with pregnancy intrahepatic cholestasis (r=-0.536, p=0.05). CONCLUSIONS: We did not show any association of RAGE and glyoxalase I gene polymorphisms with pathological pregnancy, however further studies are needed to confirm the results.
650    _2
$a dospělí $7 D000328
650    _2
$a alanintransaminasa $x krev $7 D000410
650    _2
$a antigeny nádorové $x krev $x genetika $7 D000951
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a intrahepatální cholestáza $x krev $x genetika $7 D002780
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a růstová retardace plodu $x krev $x genetika $7 D005317
650    _2
$a frekvence genu $7 D005787
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a lidé $7 D006801
650    _2
$a laktoylglutathionlyasa $x genetika $7 D007791
650    _2
$a mitogenem aktivované proteinkinasy $x krev $x genetika $7 D020928
650    _2
$a předčasná porodní činnost $x krev $x genetika $7 D007752
650    12
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a preeklampsie $x krev $x genetika $7 D011225
650    _2
$a těhotenství $7 D011247
650    _2
$a komplikace těhotenství $x krev $x genetika $7 D011248
650    _2
$a sekvenční analýza DNA $7 D017422
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Muravská, Alexandra $u -
700    1_
$a Jáchymová, Marie $u -
700    1_
$a Hájek, Zdeněk $u -
700    1_
$a Koucký, Michal $u -
700    1_
$a Mestek, Oto $u -
700    1_
$a Zima, Tomáš $u -
700    1_
$a Kalousová, Marta $u -
773    0_
$w MED00001119 $t Clinical biochemistry $x 1873-2933 $g Roč. 45, č. 16-17 (2012), s. 1409-14
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22771726 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20130708100911 $b ABA008
999    __
$a ok $b bmc $g 988070 $s 822770
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 45 $c 16-17 $d 1409-14 $i 1873-2933 $m Clinical biochemistry $n Clin Biochem $x MED00001119
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

    Možnosti archivace